Inhibikase Therapeutics Stock Price on January 31, 2025

IKT Stock  USD 2.34  0.04  1.68%   
If you're considering investing in Inhibikase Stock, it is important to understand the factors that can impact its price. As of today, the current price of Inhibikase Therapeutics stands at 2.34, as last reported on the 28th of February, with the highest price reaching 2.43 and the lowest price hitting 2.31 during the day. Currently, Inhibikase Therapeutics is dangerous. Inhibikase Therapeutics holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Inhibikase Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Inhibikase Therapeutics' Risk Adjusted Performance of 0.0071, standard deviation of 7.84, and Market Risk Adjusted Performance of 0.0272 to validate if the risk estimate we provide is consistent with the expected return of 0.0426%.
  
Inhibikase Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0054

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIKT

Estimated Market Risk

 7.87
  actual daily
70
70% of assets are less volatile

Expected Return

 0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Inhibikase Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inhibikase Therapeutics by adding Inhibikase Therapeutics to a well-diversified portfolio.

Inhibikase Therapeutics Valuation on January 31, 2025

It is possible to determine the worth of Inhibikase Therapeutics on a given historical date. On January 31, 2025 Inhibikase was worth 1.9 at the beginning of the trading date compared to the closed value of 2.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Inhibikase Therapeutics stock. Still, in general, we apply an absolute valuation method to find Inhibikase Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inhibikase Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Inhibikase Therapeutics' related companies.
 Open High Low Close Volume
  2.17    2.59    1.91    1.92    982,581  
01/31/2025
  1.90    2.29    1.90    2.27    442,326  
  2.20    2.37    2.03    2.16    227,847  
Backtest Inhibikase Therapeutics  |  Inhibikase Therapeutics History  |  Inhibikase Therapeutics Valuation PreviousNext  
Open Value
1.9
2.27
Closing Value
25.52
Upside

Inhibikase Therapeutics Trading Date Momentum on January 31, 2025

On February 03 2025 Inhibikase Therapeutics was traded for  2.16  at the closing time. Highest Inhibikase Therapeutics's price during the trading hours was 2.37  and the lowest price during the day was  2.03 . The net volume was 227.8 K. The overall trading history on the 3rd of February contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 4.85% . The trading delta at closing time to current price is 0.88% .
JavaScript chart by amCharts 3.21.1501/31/2025Jan 21Jan 24Jan 27Jan 30FebFeb 05Feb 082.02.22.42.62.8

Inhibikase Therapeutics Fundamentals Correlations and Trends

By evaluating Inhibikase Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Inhibikase Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Inhibikase financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Inhibikase Therapeutics Stock history

Inhibikase Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inhibikase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inhibikase Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inhibikase Therapeutics stock prices may prove useful in developing a viable investing in Inhibikase Therapeutics
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinsons Disease and related disorders that arise inside and outside of the brain. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia. Inhibikase Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.

Inhibikase Therapeutics Stock Technical Analysis

Inhibikase Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inhibikase Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inhibikase Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Inhibikase Therapeutics Period Price Range

Low
February 28, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Inhibikase Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Inhibikase Therapeutics February 28, 2025 Market Strength

Market strength indicators help investors to evaluate how Inhibikase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inhibikase Therapeutics shares will generate the highest return on investment. By undertsting and applying Inhibikase Therapeutics stock market strength indicators, traders can identify Inhibikase Therapeutics entry and exit signals to maximize returns

Inhibikase Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Inhibikase Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Inhibikase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inhibikase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Inhibikase Stock Analysis

When running Inhibikase Therapeutics' price analysis, check to measure Inhibikase Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibikase Therapeutics is operating at the current time. Most of Inhibikase Therapeutics' value examination focuses on studying past and present price action to predict the probability of Inhibikase Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibikase Therapeutics' price. Additionally, you may evaluate how the addition of Inhibikase Therapeutics to your portfolios can decrease your overall portfolio volatility.